Switch to:
Also traded in: Hongkong
» Details

Insider Trades

Latest Guru Trades with SLUXY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Drug Manufacturers » Drug Manufacturers - Major  
Compare:NAS:RTRX, AMEX:TXMD, OTCPK:VEGPF, NAS:ASMB, NAS:RMTI, NAS:ZGNX, NAS:OASM, NAS:ALIM, OTCPK:BIOYF, AMEX:NNVC, OTCPK:PXSLY, NAS:HCM, NAS:PRPH, AMEX:AXN, NAS:IMNP, NAS:NVGN, OTCPK:CHEXF, OTCPK:SUWN, NAS:TNXP, OTCPK:INNV » details
Traded in other countries:08058.Hongkong,
Shandong Luoxin Pharmaceutical Group Stock Co Ltd along with its subsidiaries is engaged in the manufacturing and selling of pharmaceutical products.

Shandong Luoxin Pharmacy Stock Co., Ltd. is engaged in the manufacturing and selling of pharmaceutical products.

Ratios

vs
industry
vs
history
PE Ratio 1.59
SLUXY's PE Ratio is ranked higher than
99% of the 453 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 27.06 vs. SLUXY: 1.59 )
Ranked among companies with meaningful PE Ratio only.
SLUXY' s PE Ratio Range Over the Past 10 Years
Min: 1.2  Med: 11.47 Max: 22.08
Current: 1.59
1.2
22.08
PE Ratio without NRI 1.59
SLUXY's PE Ratio without NRI is ranked higher than
99% of the 447 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 27.19 vs. SLUXY: 1.59 )
Ranked among companies with meaningful PE Ratio without NRI only.
SLUXY' s PE Ratio without NRI Range Over the Past 10 Years
Min: 1.2  Med: 11.44 Max: 22.42
Current: 1.59
1.2
22.42
PB Ratio 2.43
SLUXY's PB Ratio is ranked higher than
57% of the 606 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 2.82 vs. SLUXY: 2.43 )
Ranked among companies with meaningful PB Ratio only.
SLUXY' s PB Ratio Range Over the Past 10 Years
Min: 1.57  Med: 2.51 Max: 6.69
Current: 2.43
1.57
6.69
PS Ratio 1.64
SLUXY's PS Ratio is ranked higher than
69% of the 595 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 2.74 vs. SLUXY: 1.64 )
Ranked among companies with meaningful PS Ratio only.
SLUXY' s PS Ratio Range Over the Past 10 Years
Min: 1.24  Med: 2.02 Max: 19.38
Current: 1.64
1.24
19.38
EV-to-EBIT 12.60
SLUXY's EV-to-EBIT is ranked higher than
76% of the 455 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 19.61 vs. SLUXY: 12.60 )
Ranked among companies with meaningful EV-to-EBIT only.
SLUXY' s EV-to-EBIT Range Over the Past 10 Years
Min: 2.9  Med: 8.9 Max: 51.6
Current: 12.6
2.9
51.6
EV-to-EBITDA 12.60
SLUXY's EV-to-EBITDA is ranked higher than
67% of the 478 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 16.32 vs. SLUXY: 12.60 )
Ranked among companies with meaningful EV-to-EBITDA only.
SLUXY' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.9  Med: 8.9 Max: 51.6
Current: 12.6
2.9
51.6
PEG Ratio 0.27
SLUXY's PEG Ratio is ranked higher than
95% of the 266 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 1.80 vs. SLUXY: 0.27 )
Ranked among companies with meaningful PEG Ratio only.
SLUXY' s PEG Ratio Range Over the Past 10 Years
Min: 0.26  Med: 0.97 Max: 5.74
Current: 0.27
0.26
5.74
Days Inventory 61.68
SLUXY's Days Inventory is ranked higher than
79% of the 567 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 113.74 vs. SLUXY: 61.68 )
Ranked among companies with meaningful Days Inventory only.
SLUXY' s Days Inventory Range Over the Past 10 Years
Min: 61.68  Med: 102.71 Max: 143.55
Current: 61.68
61.68
143.55

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 3.91
SLUXY's Dividend Yield % is ranked higher than
89% of the 632 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 1.62 vs. SLUXY: 3.91 )
Ranked among companies with meaningful Dividend Yield % only.
SLUXY' s Dividend Yield % Range Over the Past 10 Years
Min: 0.18  Med: 2.31 Max: 5.55
Current: 3.91
0.18
5.55
Dividend Payout Ratio 0.52
SLUXY's Dividend Payout Ratio is ranked lower than
66% of the 378 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 0.36 vs. SLUXY: 0.52 )
Ranked among companies with meaningful Dividend Payout Ratio only.
SLUXY' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.05  Med: 0.15 Max: 0.52
Current: 0.52
0.05
0.52
3-Year Dividend Growth Rate 13.80
SLUXY's 3-Year Dividend Growth Rate is ranked higher than
60% of the 270 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 8.20 vs. SLUXY: 13.80 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
SLUXY' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 30.2 Max: 122.1
Current: 13.8
0
122.1
Forward Dividend Yield % 3.91
SLUXY's Forward Dividend Yield % is ranked higher than
87% of the 612 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 1.60 vs. SLUXY: 3.91 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 39.61
SLUXY's 5-Year Yield-on-Cost % is ranked higher than
99% of the 771 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 2.14 vs. SLUXY: 39.61 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
SLUXY' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.82  Med: 23.4 Max: 56.22
Current: 39.61
1.82
56.22

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 15.29
SLUXY's Price-to-Net-Cash is ranked lower than
99.99% of the 136 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 14.43 vs. SLUXY: 15.29 )
Ranked among companies with meaningful Price-to-Net-Cash only.
SLUXY' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 0  Med: 9.99 Max: 124.8
Current: 15.29
0
124.8
Price-to-Net-Current-Asset-Value 4.20
SLUXY's Price-to-Net-Current-Asset-Value is ranked lower than
99.99% of the 337 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 7.44 vs. SLUXY: 4.20 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
SLUXY' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0  Med: 4.39 Max: 8.61
Current: 4.2
0
8.61
Price-to-Tangible-Book 2.43
SLUXY's Price-to-Tangible-Book is ranked higher than
64% of the 546 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 3.50 vs. SLUXY: 2.43 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
SLUXY' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.52  Med: 2.51 Max: 5.6
Current: 2.43
1.52
5.6
Price-to-Intrinsic-Value-DCF (Earnings Based) 0.06
SLUXY's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
99% of the 74 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 1.35 vs. SLUXY: 0.06 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 0.81
SLUXY's Price-to-Median-PS-Value is ranked higher than
82% of the 538 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 1.22 vs. SLUXY: 0.81 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
SLUXY' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.62  Med: 0.98 Max: 7.62
Current: 0.81
0.62
7.62
Price-to-Graham-Number 1.21
SLUXY's Price-to-Graham-Number is ranked lower than
99.99% of the 331 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 2.17 vs. SLUXY: 1.21 )
Ranked among companies with meaningful Price-to-Graham-Number only.
SLUXY' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0  Med: 1.15 Max: 1.93
Current: 1.21
0
1.93
Earnings Yield (Greenblatt) % 7.90
SLUXY's Earnings Yield (Greenblatt) % is ranked higher than
82% of the 611 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 3.50 vs. SLUXY: 7.90 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
SLUXY' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 1.9  Med: 11.3 Max: 34.5
Current: 7.9
1.9
34.5
Forward Rate of Return (Yacktman) % 1.75
SLUXY's Forward Rate of Return (Yacktman) % is ranked lower than
63% of the 353 Companies
in the Global Drug Manufacturers - Major industry.

( Industry Median: 10.48 vs. SLUXY: 1.75 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
SLUXY' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 1.75  Med: 9.1 Max: 40.3
Current: 1.75
1.75
40.3

More Statistics

Revenue (TTM) (Mil) $593.4
EPS (TTM) $ 10.04
Beta0.28
Short Percentage of Float0.00%
52-Week Range $12.81 - 17.47
Shares Outstanding (Mil)60.96
» More Articles for SLUXY

Headlines

Articles On GuruFocus.com

More From Other Websites
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. :SLUXY-US: Earnings Analysis: Q3, 2016 By the... Nov 23 2016
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. : SLUXY-US: Dividend Analysis : June 24th, 2016... Oct 21 2016
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. :SLUXY-US: Earnings Analysis: Q2, 2016 By the... Aug 11 2016
ETF’s with exposure to Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. : June 24, 2016 Jun 24 2016
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. :SLUXY-US: Earnings Analysis: Q1, 2016 By the... May 26 2016
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. :SLUXY-US: Earnings Analysis: 2015 By the... Mar 24 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK